Exalate Launches Advanced Freshservice Connector, Eliminating Manual IT Handoffs for Enterprise Teams

New integration solution enables real-time synchronization between Freshservice and other key business systems, protecting SLAs and streamlining complex IT environments. ANTWERP, BELGIUM / ACCESS Newswire / July 2, 2025 / Exalate, a leading provider of secure and flexible integration, today announced the launch of Exalate for Freshservice, a real-time connector that synchronizes critical IT service […]

GDS Announces the Final Offering Price for its C-REIT Initial Public Offering on the Shanghai Stock Exchange

GDS Announces the Final Offering Price for its C-REIT Initial Public Offering on the Shanghai Stock Exchange GlobeNewswire July 02, 2025 SHANGHAI, China, July 02, 2025 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced

ASSOCIATION OF CORPORATE COUNSEL (ACC) LAUNCHES AI CENTER OF EXCELLENCE TO EMPOWER IN-HOUSE LEGAL PROFESSIONALS

WASHINGTON, July 02, 2025 (GLOBE NEWSWIRE) — The Association of Corporate Counsel (ACC), the world's premier organization for in-house legal professionals, is proud to announce the launch of the ACC AI Center of Excellence for In-House Counsel, a dynamic, member-driven resource designed to support in-house counsel as they navigate the evolving landscape of artificial intelligence.

VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202

(NASDAQ:VYNE), BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need, today provided a program update for VYN202 following the clinical hold issued by the U.S. Food and

VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202

VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202 GlobeNewswire July 02, 2025 BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need, today provided a program

ASSOCIATION OF CORPORATE COUNSEL (ACC) LAUNCHES AI CENTER OF EXCELLENCE TO EMPOWER IN-HOUSE LEGAL PROFESSIONALS

ASSOCIATION OF CORPORATE COUNSEL (ACC) LAUNCHES AI CENTER OF EXCELLENCE TO EMPOWER IN-HOUSE LEGAL PROFESSIONALS GlobeNewswire July 02, 2025 WASHINGTON, July 02, 2025 (GLOBE NEWSWIRE) — The Association of Corporate Counsel (ACC), the world's premier organization for in-house legal professionals, is proud to announce the launch of the ACC AI Center of Excellence for In-House

Hivello buys back 13.5M HVLO under Buy & Burn initiative

Hivello buys back 13.5M HVLO under Buy & Burn initiative GlobeNewswire July 02, 2025 TORONTO, July 02, 2025 (GLOBE NEWSWIRE) — Blockmate Ventures Inc (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH1) (“Blockmate” or the “Company“) is pleased to announce that its investee, Hivello Holdings, has completed the first batch of its quarterly Buy & Burn initiative,

Class Action Filed Against 3D Systems Corporation (DDD) Over Securities Violations – Contact Levi & Korsinsky Today

NEW YORK, NY / ACCESS Newswire / July 2, 2025 / If you suffered a loss on your 3D Systems Corporation (NYSE:DDD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/3d-systems-corporation-lawsuit-submission-form?prid=155225&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Class Action Alert: Levi & Korsinsky Reminds DoubleVerify Holdings, Inc. (DV) Investors of July 21, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / July 2, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=155217&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Cytokinetics, Incorporated (CYTK) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

NEW YORK, NY / ACCESS Newswire / July 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has

Scroll to Top